#160866

Anti-PAX-FOXO1 [PaxF]

Cat. #160866

Anti-PAX-FOXO1 [PaxF]

Cat. #: 160866

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-5 days

Target: The junction region of the PAX3-FOXO1 and the PAX7-FOXO1 fusion proteins

Class: Monoclonal

Application: ChIP ; IHC ; IF ; IP ; WB ; ChIP-seq

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: National Human Genome Research Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-PAX-FOXO1 [PaxF]
  • Alternate name: PFM.2
  • Clone: PaxF
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 105 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ChIP ; IHC ; IF ; IP ; WB ; ChIP-seq
  • Description: Alveolar Rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer and cases with fusion oncoproteins PAX7-FOXO1 and PAX3-FOXO1 have a poor prognosis. Determination of the fusion status is important for RMS diagnostics and therapies. This antibody is specific for the PAX3-FOXO1 and PAX7-FOXO1 and therefore is a valuable tool to study the oncogenesis of ARMS
  • Immunogen: KLH conjugated with peptide PF corresponding to the PAX3-FOXO1 translocation region aa 100-117 (TIGNGLSPQNSIRHNLSL) in Freund’s adjuvant
  • Isotype: IgG2b kappa
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: Cell lysate from FP-RMS lines (e.g., RH-4, RH-28, RH-30, RMS-13)

Target Details

  • Target: The junction region of the PAX3-FOXO1 and the PAX7-FOXO1 fusion proteins
  • Molecular weight: 105 kDa

Applications

  • Application: ChIP ; IHC ; IF ; IP ; WB ; ChIP-seq

Handling

  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Azorsa et al. 2021. Mod Pathol. 34(4):748-757. PMID: 33299109.
  • Gryder et al. 2017. Cancer Discov. 7(8):884-899. PMID: 28446439.
  • Cao et al. 2010. Cancer Res. 70(16):6497-508. PMID: 20663909.
  • Khan et al. 1999. Proc Natl Acad Sci U S A. 96(23):13264-9. PMID: 10557309.